No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / pharmacology
-
Apoptosis* / drug effects
-
Cell Line, Tumor
-
ErbB Receptors* / metabolism
-
Extracellular Signal-Regulated MAP Kinases / metabolism
-
Humans
-
Niacinamide / administration & dosage
-
Niacinamide / analogs & derivatives
-
Niacinamide / pharmacology
-
Phenylurea Compounds* / administration & dosage
-
Phenylurea Compounds* / pharmacology
-
Phosphatidylinositol 3-Kinases / metabolism
-
Proto-Oncogene Proteins c-akt* / metabolism
-
Signal Transduction* / drug effects
-
Sorafenib* / administration & dosage
-
Sorafenib* / pharmacology
-
Triterpenes* / administration & dosage
-
Triterpenes* / pharmacology
-
Vascular Endothelial Growth Factor A* / metabolism
-
raf Kinases* / metabolism
-
ras Proteins / metabolism
Substances
-
Sorafenib
-
Proto-Oncogene Proteins c-akt
-
ErbB Receptors
-
Phenylurea Compounds
-
Triterpenes
-
Vascular Endothelial Growth Factor A
-
raf Kinases
-
Phosphatidylinositol 3-Kinases
-
Niacinamide
-
ras Proteins
-
Antineoplastic Agents
-
Extracellular Signal-Regulated MAP Kinases
-
EGFR protein, human